Drug Shortage Report for ATROPINE SULFATE INJECTION
Report ID | 146183 |
Drug Identification Number | 02426269 |
Brand name | ATROPINE SULFATE INJECTION |
Common or Proper name | Atropine Sulfate Injection |
Company Name | LABORATOIRE AGUETTANT |
Market Status | MARKETED |
Active Ingredient(s) | ATROPINE SULFATE |
Strength(s) | 0.5MG |
Dosage form(s) | SOLUTION |
Route of administration | SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR |
Packaging size | 0.5 mg/5mL pre-filled syringe. 10 syringes per carton. |
ATC code | A03BA |
ATC description | BELLADONNAAND DERIVATIVES, PLAIN |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2021-10-08 |
Actual start date | |
Estimated end date | 2021-10-22 |
Actual end date | 2021-10-18 |
Shortage status | Resolved |
Updated date | 2021-10-18 |
Company comments | Unanticipated heavy demand increase for drug. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1, RUE ALEXANDER FLEMING LYON, RHÔNE FRANCE 69007 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2021-10-18 | French | Compare |
v5 | 2021-10-18 | English | Compare |
v4 | 2021-10-09 | English | Compare |
v3 | 2021-09-24 | French | Compare |
v2 | 2021-09-24 | English | Compare |
v1 | 2021-09-24 | English | Compare |
Showing 1 to 6 of 6